ABITREXATE Drug Patent Profile
✉ Email this page to a colleague
When do Abitrexate patents expire, and what generic alternatives are available?
Abitrexate is a drug marketed by Abic and is included in four NDAs.
The generic ingredient in ABITREXATE is methotrexate sodium. There are twenty drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Abitrexate
A generic version of ABITREXATE was approved as methotrexate sodium by HIKMA on September 16th, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ABITREXATE?
- What are the global sales for ABITREXATE?
- What is Average Wholesale Price for ABITREXATE?
Summary for ABITREXATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 137 |
| Clinical Trials: | 96 |
| DailyMed Link: | ABITREXATE at DailyMed |
Recent Clinical Trials for ABITREXATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| City of Hope Medical Center | Phase 2 |
| Children's Oncology Group | Phase 2/Phase 3 |
| Children's Oncology Group | Phase 1/Phase 2 |
US Patents and Regulatory Information for ABITREXATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abic | ABITREXATE | methotrexate sodium | INJECTABLE;INJECTION | 089161-001 | Mar 10, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abic | ABITREXATE | methotrexate sodium | INJECTABLE;INJECTION | 089356-001 | Jul 17, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abic | ABITREXATE | methotrexate sodium | INJECTABLE;INJECTION | 089354-001 | Jul 17, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abic | ABITREXATE | methotrexate sodium | INJECTABLE;INJECTION | 089355-001 | Jul 17, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
